Combination of EGFR and MEK1/2 Inhibitor Shows Synergistic Effects by Suppressing EGFR/HER3-dependent AKT Activation in Human Gastric Cancer Cells

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-09-0300
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Feedback Activation of HER3 Attenuates Response to EGFR Inhibitors in Colon Cancer Cells

Oncotarget
Oncology
2016English

Emodin Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitor Through Suppressing Stat3 Signaling Pathway

Cancer Management and Research
Oncology
2019English

EZH2 Inhibition Enhances the Efficacy of an EGFR Inhibitor in Suppressing Colon Cancer Cells

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2014English

Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and Is Synergistic With Trastuzumab in Vitro and in Vivo

Clinical Cancer Research
Cancer ResearchOncology
2010English

EGFR Inhibitor C225 Increases the Radio-Sensitivity of Human Breast Cancer Cells

Asian Pacific Journal of Cancer Prevention
2019English

ETS1 Mediates MEK1/2-Dependent Overexpression of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Human Cancer Cells

PLoS ONE
Multidisciplinary
2011English

Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer

Science Signaling
BiochemistryCell BiologyMolecular Biology
2014English

Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells Through Downregulation of Akt

Journal of Cancer
Oncology
2011English

Akt Activation by Ca2+/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) in Ovarian Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy